Can venlafaxine cause constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Venlafaxine Cause Constipation?

Yes, venlafaxine does cause constipation, occurring in approximately 15% of patients compared to 7% with placebo, making it a common and clinically significant adverse effect of this medication. 1

Evidence from FDA Drug Labeling

The FDA-approved prescribing information for venlafaxine explicitly lists constipation as one of the common adverse effects 1. In controlled clinical trials, constipation occurred in 15% of venlafaxine-treated patients versus 7% of placebo-treated patients 1. This represents more than double the placebo rate, establishing a clear drug-related effect.

Importantly, constipation is listed among the most commonly observed adverse events (≥5% incidence and at least twice the placebo rate) that patients should be counseled about when starting venlafaxine 1.

Mechanism and Clinical Context

Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) 2, 3. While the guidelines note that antidepressants, particularly tricyclic antidepressants, are commonly associated with constipation 4, the evidence shows that SNRIs like venlafaxine also cause this effect, though potentially through different mechanisms than tricyclics 5.

The 2025 systematic review on constipation notes that selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) offer alternatives to tricyclic antidepressants when constipation is a concern 5, suggesting these newer agents may have a somewhat more favorable profile—but they still cause constipation.

Comparative Data

Research comparing venlafaxine to other antidepressants confirms this adverse effect:

  • A 2009 study found that constipation was significantly more common with venlafaxine than fluoxetine 6
  • A 2004 study showed more venlafaxine-treated patients had constipation compared to escitalopram (p < 0.05) 7
  • A 2021 meta-analysis examining gastrointestinal side effects of antidepressants found venlafaxine was associated with constipation, though the specific rates varied by compound 8

Desvenlafaxine (the active metabolite of venlafaxine) also causes constipation, with this being one of the most common treatment-emergent adverse events in clinical trials 9.

Clinical Management Considerations

When prescribing venlafaxine, proactively counsel patients about constipation risk and implement preventive measures:

  • Increase fluid intake
  • Increase dietary fiber (if adequate fluid intake is maintained)
  • Encourage physical activity when appropriate 4

If constipation develops:

  • Rule out impaction (especially if diarrhea accompanies constipation, suggesting overflow)
  • Rule out obstruction
  • Assess for other contributing factors (hypercalcemia, hypokalemia, hypothyroidism, diabetes, other constipating medications) 4

Treatment approach:

  • Add bisacodyl 10-15 mg daily to three times daily, targeting one non-forced bowel movement every 1-2 days 4
  • Consider adding stool softeners, though evidence suggests stimulant laxatives alone may be sufficient 4
  • If constipation persists, consider additional laxatives: polyethylene glycol, lactulose, magnesium hydroxide, or magnesium citrate 4

Important Caveats

The constipation risk with venlafaxine must be weighed against its therapeutic benefits for depression and anxiety disorders. The 15% incidence, while significant, means most patients (85%) will not experience this side effect. However, providers should not dismiss constipation as trivial—the palliative care guidelines emphasize that constipation causes both physical discomfort and psychological distress 4.

If constipation becomes problematic and unresponsive to standard management, consider whether an alternative antidepressant with a lower constipation profile (such as escitalopram based on comparative data) might be appropriate, balancing this against the patient's response to venlafaxine for their psychiatric condition.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.